Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 3.7700 |
| Open | 3.9200 |
| Bid | 3.9300 x 700 |
| Ask | 3.9900 x 600 |
| Day's range | 3.8800 - 4.0700 |
| 52-week range | 3.2100 - 37.9800 |
| Volume | |
| Avg. volume | 1,872,486 |
| Market cap | 411.653M |
| Beta (5Y monthly) | 1.09 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
NASHVILLE, Tenn., May 02, 2024--Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024
- Business Wire
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
NASHVILLE, Tenn., April 12, 2024--Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
- Business Wire
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NASHVILLE, Tenn., March 27, 2024--Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
© 2024 Yahoo. All rights reserved.